TipRanks
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
HRMY
Harmony Biosciences Holdings
RESEARCH TOOLSreports
Want to see HRMY full AI Analyst Report?

Harmony Biosciences Holdings (HRMY) Ratios

455 Followers

Harmony Biosciences Holdings Ratios

HRMY's free cash flow for Q2 2026 was $0.76. For the 2026 fiscal year, HRMY's free cash flow was decreased by $ and operating cash flow was $0.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.48 3.60 3.31 2.75 5.07
Quick Ratio
 3.45 3.58 3.27 2.72 5.02
Cash Ratio
 2.35 2.98 2.59 1.90 3.09
Solvency Ratio
 0.55 0.46 0.50 0.44 0.76
Operating Cash Flow Ratio
 1.52 1.38 1.26 1.34 1.83
Short-Term Operating Cash Flow Coverage
 17.75 4.01 13.53 14.63 72.23
Net Current Asset Value
$ 440.49M$ 505.60M$ 239.21M$ 106.61M$ 129.25M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.19 0.18 0.24 0.28
Debt-to-Equity Ratio
 0.15 0.28 0.28 0.41 0.48
Debt-to-Capital Ratio
 0.13 0.22 0.22 0.29 0.32
Long-Term Debt-to-Capital Ratio
 0.12 0.15 0.20 0.28 0.32
Financial Leverage Ratio
 1.37 1.46 1.52 1.74 1.67
Debt Service Coverage Ratio
 6.47 1.96 5.54 4.57 10.75
Interest Coverage Ratio
 17.11 14.23 10.91 8.08 6.39
Debt to Market Cap
 0.07 0.11 0.09 0.10 0.06
Interest Debt Per Share
 2.89 4.42 3.50 3.65 3.56
Net Debt to EBITDA
 -1.43 -2.01 -1.16 -0.53 -0.35
Profitability Margins
Gross Profit Margin
75.42%77.16%78.06%79.17%80.93%
EBIT Margin
26.15%26.45%29.28%33.87%28.20%
EBITDA Margin
28.79%29.37%32.66%38.06%33.54%
Operating Profit Margin
24.03%24.00%26.70%32.99%27.45%
Pretax Profit Margin
25.13%24.76%26.84%29.79%23.91%
Net Profit Margin
18.88%18.27%20.36%22.14%41.44%
Continuous Operations Profit Margin
18.88%18.27%20.36%22.14%41.44%
Net Income Per EBT
75.15%73.79%75.86%74.31%173.35%
EBT Per EBIT
104.57%103.16%100.51%90.30%87.10%
Return on Assets (ROA)
13.20%12.48%14.56%15.88%26.93%
Return on Equity (ROE)
20.06%18.24%22.07%27.59%45.05%
Return on Capital Employed (ROCE)
20.25%20.45%23.16%29.65%20.20%
Return on Invested Capital (ROIC)
14.96%13.90%17.20%21.53%20.13%
Return on Tangible Assets
13.99%13.42%16.42%19.11%35.38%
Earnings Yield
7.96%7.38%7.43%6.71%5.57%
Efficiency Ratios
Receivables Turnover
 8.65 8.97 8.61 7.85 8.00
Payables Turnover
 10.88 11.21 11.41 6.84 22.05
Inventory Turnover
 37.09 37.02 21.79 22.61 19.43
Fixed Asset Turnover
 0.00 162.51 211.52 1.57K 764.14
Asset Turnover
 0.70 0.68 0.72 0.72 0.65
Working Capital Turnover Ratio
 1.68 1.64 2.07 1.91 1.59
Cash Conversion Cycle
 18.50 17.98 27.17 9.26 47.87
Days of Sales Outstanding
 42.21 40.68 42.40 46.49 45.63
Days of Inventory Outstanding
 9.84 9.86 16.75 16.15 18.79
Days of Payables Outstanding
 33.55 32.56 31.99 53.38 16.55
Operating Cycle
 52.05 50.54 59.16 62.64 64.42
Cash Flow Ratios
Operating Cash Flow Per Share
 6.14 6.06 3.86 3.69 2.44
Free Cash Flow Per Share
 6.13 6.05 3.84 3.68 2.44
CapEx Per Share
 <0.01 <0.01 0.02 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.99 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 1.99K 1.12K 190.65 703.16 839.92
Capital Expenditure Coverage Ratio
 1.99K 1.12K 190.65 703.16 839.92
Operating Cash Flow Coverage Ratio
 2.31 1.45 1.21 1.13 0.75
Operating Cash Flow to Sales Ratio
 0.37 0.40 0.31 0.38 0.33
Free Cash Flow Yield
15.58%16.17%11.17%11.40%4.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.57 13.56 13.44 14.91 17.97
Price-to-Sales (P/S) Ratio
 2.37 2.48 2.74 3.30 7.45
Price-to-Book (P/B) Ratio
 2.28 2.47 2.97 4.11 8.09
Price-to-Free Cash Flow (P/FCF) Ratio
 6.42 6.18 8.95 8.77 22.60
Price-to-Operating Cash Flow Ratio
 6.41 6.18 8.90 8.76 22.57
Price-to-Earnings Growth (PEG) Ratio
 -9.96 1.74 0.75 -0.51 0.04
Enterprise Value Multiple
 6.81 6.42 7.22 8.14 21.85
Enterprise Value
 1.88B 1.64B 1.69B 1.80B 3.21B
EV to EBITDA
 6.81 6.42 7.22 8.14 21.85
EV to Sales
 1.96 1.89 2.36 3.10 7.33
EV to Free Cash Flow
 5.30 4.71 7.71 8.23 22.23
EV to Operating Cash Flow
 5.30 4.71 7.67 8.22 22.21
Tangible Book Value Per Share
 15.93 13.58 9.60 5.55 4.09
Shareholders’ Equity Per Share
 17.27 15.14 11.59 7.85 6.81
Tax and Other Ratios
Effective Tax Rate
 0.25 0.26 0.24 0.26 -0.73
Revenue Per Share
 16.59 15.11 12.56 9.79 7.40
Net Income Per Share
 3.13 2.76 2.56 2.17 3.07
Tax Burden
 0.75 0.74 0.76 0.74 1.73
Interest Burden
 0.96 0.94 0.92 0.88 0.85
Research & Development to Revenue
 0.23 0.22 0.20 0.13 0.16
SG&A to Revenue
 0.28 0.31 0.31 0.16 0.19
Stock-Based Compensation to Revenue
 0.04 0.05 0.06 0.05 0.06
Income Quality
 1.96 2.19 1.51 1.70 0.80
Currency in USD